SPECTRUM PHARMACEUTICALS, INC.

Spectrum Pharmaceuticals, Inc. ( Spectrum) is a commercial stage biopharmaceutical company, engaged in developing and commercializing therapies with a focus primarily in the areas of hematology-oncology and urology. The Company's product is apaziquone (formerly EOquin), which is in two Phase 3 clinical trials for non-muscle invasive bladder cancer under a collaboration with Allergan Inc. Another drug, ozarelix is in a Phase 2 clinical trial for benign prostatic hypertrophy (BPH). On December 15, 2008, Spectrum and Cell Therapeutics, Inc. (CTI) partnered to form a joint venture, RIT Oncology, LLC ...


Scholarships

There are no scholarships at this time

 Events

There are no events at this time

Company Data on SPECTRUM PHARMACEUTICALS, INC.
provided by Owler


 

SPECTRUM PHARMACEUTICALS, INC. is hiring for these positions

Show me: All available jobs
loading